Malignant neoplasm of breast
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Prostate Cancer, Hereditary, 9
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Prostate Cancer, Hereditary, 9
|
0.400 |
Biomarker
|
disease |
CTD_human |
|
|
|
Malignant tumor of colon
|
0.120 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Malignant neoplasm of ovary
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
PROSTATE CANCER, SUSCEPTIBILITY TO
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Neoplastic Syndromes, Hereditary
|
0.100 |
GeneticVariation
|
group |
CLINVAR |
Hoxb-13: a new Hox gene in a distant region of the HOXB cluster maintains colinearity.
|
8756292 |
1996 |
Dermatologic disorders
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Expression in hyperproliferative skin conditions remained cytoplasmic with the exception of epidermis associated with Kaposi's sarcoma, which showed strong HOXB13 expression that was partially localized to the nucleus.
|
12761847 |
2003 |
Malignant neoplasm of prostate
|
0.600 |
Biomarker
|
disease |
BEFREE |
In addition to the loss of HOXB13 expression, maintaining AR may be an important step for prostate cancer cells to tolerate the suppressor function of HOXB13.
|
15604291 |
2004 |
Malignant neoplasm of breast
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Ectopic expression of HOXB13 in MCF10A breast epithelial cells enhances motility and invasion in vitro, and its expression is increased in both preinvasive and invasive primary breast cancer.
|
15193263 |
2004 |
Breast Carcinoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Ectopic expression of HOXB13 in MCF10A breast epithelial cells enhances motility and invasion in vitro, and its expression is increased in both preinvasive and invasive primary breast cancer.
|
15193263 |
2004 |
Prostatic Neoplasms
|
0.380 |
AlteredExpression
|
group |
LHGDN |
HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4.
|
15126340 |
2004 |
Prostatic Neoplasms
|
0.380 |
AlteredExpression
|
group |
LHGDN |
HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling.
|
15604291 |
2004 |
Prostate carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
In addition to the loss of HOXB13 expression, maintaining AR may be an important step for prostate cancer cells to tolerate the suppressor function of HOXB13.
|
15604291 |
2004 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
However, the function of HOXB13 in normal cell growth and tumorigenesis is not yet known.
|
15126340 |
2004 |
Tumor Cell Invasion
|
0.070 |
AlteredExpression
|
phenotype |
BEFREE |
Ectopic expression of HOXB13 in MCF10A breast epithelial cells enhances motility and invasion in vitro, and its expression is increased in both preinvasive and invasive primary breast cancer.
|
15193263 |
2004 |
Early-Stage Breast Carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
The HOXB13:IL17BR expression ratio may be useful for identifying patients appropriate for alternative therapeutic regimens in early-stage breast cancer.
|
15193263 |
2004 |
Malignant neoplasm of prostate
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Quantitative RT-PCR demonstrated the specificity of expression of HOXB13 in prostate tissue and revealed its ubiquitous expression in a series of 37 primary prostate cancers and 20 normal prostates.
|
15583692 |
2005 |
Prostate carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer.
|
15583692 |
2005 |
Neoplastic Syndromes, Hereditary
|
0.100 |
GeneticVariation
|
group |
CLINVAR |
Hoxb13 up-regulates transglutaminase activity and drives terminal differentiation in an epidermal organotypic model.
|
15964834 |
2005 |
Carcinogenesis
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
To study the role of HOXB13 in colorectal tumorigenesis, we evaluated the expression of HOXB13 in 53 colorectal tumours originated from the distal left colon to rectum with their matching normal tissues using quantitative RT-PCR analysis.
|
15928669 |
2005 |
Colorectal Carcinoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
This is the first description of the downregulation of HOXB13 in CRC and its mechanism of action is mediated through the regulation of TCF4 protein stability.
|
15928669 |
2005 |
Malignant neoplasm of colon and/or rectum
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation.
|
15928669 |
2005 |
Endometrial Neoplasms
|
0.010 |
Biomarker
|
group |
LHGDN |
Regulation of tumor invasion by HOXB13 gene overexpressed in human endometrial cancer.
|
15756448 |
2005 |
Mammary Neoplasms
|
0.360 |
Biomarker
|
group |
LHGDN |
The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.
|
17008703 |
2006 |